35 related articles for article (PubMed ID: 10490301)
1. Alopecia areata: Time for position statement to include new systemic therapeutic advances.
Seneschal J
J Eur Acad Dermatol Venereol; 2024 Apr; 38(4):631-632. PubMed ID: 38523486
[No Abstract] [Full Text] [Related]
2. Evaluating the role of COVID-19 vaccines in the landscape of medication-induced alopecia areata.
Buontempo MG; Alhanshali L; Shapiro J; Lo Sicco K
J Am Acad Dermatol; 2024 Jan; 90(1):e45-e46. PubMed ID: 37776902
[No Abstract] [Full Text] [Related]
3. Alopecia areata: a new treatment plan.
Alsantali A
Clin Cosmet Investig Dermatol; 2011; 4():107-15. PubMed ID: 21833161
[TBL] [Abstract][Full Text] [Related]
4. Systemic treatment for alopecia areata.
Otberg N
Dermatol Ther; 2011; 24(3):320-5. PubMed ID: 21689241
[TBL] [Abstract][Full Text] [Related]
5. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
[TBL] [Abstract][Full Text] [Related]
6. Partial response of severe alopecia areata to cyclosporine A.
Ferrando J; Grimalt R
Dermatology; 1999; 199(1):67-9. PubMed ID: 10449964
[No Abstract] [Full Text] [Related]
7. The impact of cyclosporine on the development of immunosuppressive therapy for pediatric liver transplantation.
Burdelski MM
Transplant Proc; 2004 Mar; 36(2 Suppl):295S-298S. PubMed ID: 15041356
[TBL] [Abstract][Full Text] [Related]
8. Multifocal alopecia areata during systemic cyclosporine A therapy.
Cerottini JP; Panizzon RG; de Viragh PA
Dermatology; 1999; 198(4):415-7. PubMed ID: 10490301
[No Abstract] [Full Text] [Related]
9. Alopecia areata presenting in 2 kidney-pancreas transplant recipients taking cyclosporine.
Phillips MA; Graves JE; Nunley JR
J Am Acad Dermatol; 2005 Nov; 53(5 Suppl 1):S252-5. PubMed ID: 16227102
[TBL] [Abstract][Full Text] [Related]
10. [Controversies about the use of calcineurin inhibitors in pediatric patients].
Dello Strologo L
G Ital Nefrol; 2008; 25(3):317-24. PubMed ID: 18473303
[TBL] [Abstract][Full Text] [Related]
11. Experience with cyclosporine.
Langone AJ; Helderman JH
Transplant Proc; 2004 Mar; 36(2 Suppl):59S-63S. PubMed ID: 15041308
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
